ELYRIA, Ohio — Invacare announced Friday that Doug Newlin, senior vice president of global engineering, will assume leadership of the company's regulatory team in place of Colleen Craven, chief compliance officer, who has resigned for personal reasons. Newlin has experience working with the Food & Drug Administration from his time at Fenwal, a medical device company and former division of Baxter International.
"We are fortunate that Doug's experience allows him to step into this role, while we are actively recruiting for Colleen's replacement. Invacare has many important initiatives underway to enhance its corporate compliance procedures, and we will continue to add resources and expertise to our regulatory affairs and compliance functions," said Gerald B. Blouch, president and CEO, in a release.